Salazar E

Language: Spanish
References: 10
Page: 160-163
PDF size: 36.95 Kb.

ABSTRACT

Pregnancy can cause life-threatening complications in women with rheumatic heart disease. Mitral stenosis is the most common valvular lesion found in the gravida. Percutaneous mitral balloon commissurotomy has emerged as a safe and effective procedure in symptomatic pregnant patients. Immediate clinical and hemodynamic improvement was observed in 8 pregnant women treated by the Inoue technique at the Institute. The procedure was well tolerated by the fetus. Thirteen gravid patients with rheumatic valvular disease have undergone open heart surgery at the Institute. Maternal mortality was 15.4% and was related to the critical preoperative condition. Because of the high fetal mortality (38.5%) these procedures should be indicated only in extreme emergencies.
The management of women with prosthetic heart valves during pregnancy poses a particular challenge. At the Institute 393 pregnancies have been studied in 304 women with these valves. Patients with mechanical prostheses require anticoagulant therapy to prevent thromboembolic phenomena. Coumarin agents provide adequate protection against these complications but their use was associated in our series with an increased abortion rate (26.7%) and with an incidence of coumarin embryopathy of 4.1%. Different regimens of subcutaneous heparin have not been effective to prevent prosthetic thrombosis (5.2% in our cases). Controversy exists regarding the appropriate treatment of these patients.
Patients with bioprostheses may not require anticoagulation. However the limited duration of these valves is a significant disadvantage in these women.

REFERENCES

1. SULLIVAN HJ: Valvular heart surgery during pregnancy. Surg Clin N America 1995; 75: 59-75.

2. MARTÍNEZ-REDING J, CORDERO A, KURI J, MARTÍNEZ-RÍOS MA, SALAZAR E: Treatment of mitral stenosis with percutaneous balloon valvotomy in pregnant patients. Clin Cardiol 1998; 21: 659-663.

3. PRESBITERO P, PREVER SB, BRUSCA A: Interventional cardiology in pregnancy. Eur Heart J 1996; 17: 182-188.

4. BONOW RO, CARABELLO B, DE LEÓN AC JR, EDMUNDS LH, FEDDERLY BJ, FREED MD, ET AL: ACC/AHA Guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 1998; 32: 1486-1588.

5. PARRY AJ, WESTABY S: Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 1996; 61: 1865-1869.

6. SALAZAR E, IZAGUIRRE R, VERDEJO J, MUTCHINICK O: Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996; 27: 1698-1703.

7. SALAZAR E, ESPINOLA N, ROMAN L, CASANOVA JM: Effect of pregnancy on the duration of bovine pericardial bioprostheses. Am Heart J 1999; 137: 714-720.

8. CHAN WS, ANAND S, GINSBERG JS: Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2000; 160: 191-196.

9. HIRSH J, SALAZAR E: Managing anticoagulation for valve prosthesis during pregnancy. Meet the Experts Session, 1995 American College of Cardiology Annual Scientific Session. ACC Curr J Rev 1995; 4: 48-49.

10. ELKAYAM U: Pregnancy through a prosthetic heart valve. J Am Coll Cardiol 1999; 33: 1642-1645.